Comparison of clinical efficacy and bleeding risk between ticagrelor and clopidogrel in elderly patients after percutaneous coronary intervention: A retrospective study. [PDF]
Luo J, Liang G, Chen A.
europepmc +1 more source
High on-clopidogrel platelet reactivity among diabetic female patients with acute ischaemic stroke. [PDF]
Bustami M +15 more
europepmc +1 more source
Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y<sub>12</sub> Inhibitor Therapy. [PDF]
Malavé JG +12 more
europepmc +1 more source
Re: Comments on "Association of Clopidogrel Genetic Polymorphism With Efficacy and Safety for Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Updated Meta-Analysis". [PDF]
Park H, Song TJ.
europepmc +1 more source
Analysis of Treatment Pattern of Antiplatelet in First-Ever Ischemic Stroke Without Previous Antiplatelet Use: A Real-World Distributed Network Analysis of 11 Observational Korean Databases Using a Common Data Model. [PDF]
Park SH +18 more
europepmc +1 more source
Comparison of efficacy and safety between TIcagrelor and clopidogrel in Chinese patients with acute coronary syndrome (COSTIC study). [PDF]
Huang M +18 more
europepmc +1 more source
Comparative Efficacy of Ticagrelor and Clopidogrel in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging-Based Pilot Study. [PDF]
Wang WT +9 more
europepmc +1 more source
Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]
Li Y, Gong J, Liu N.
europepmc +1 more source
Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]
Ren Z +10 more
europepmc +1 more source

